Inhibiting galectin-1 reduces murine lung metastasis with increased CD4+ and CD8+ T cells and reduced cancer cell adherence
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibiting galectin-1 reduces murine lung metastasis with increased CD4+ and CD8+ T cells and reduced cancer cell adherence
Authors
Keywords
-
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume 29, Issue 6, Pages 561-572
Publisher
Springer Nature
Online
2012-04-07
DOI
10.1007/s10585-012-9471-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell surface glycan–lectin interactions in tumor metastasis
- (2011) Neela D.S. Rambaruth et al. ACTA HISTOCHEMICA
- Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress
- (2011) Koichi Ito et al. ANGIOGENESIS
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis
- (2011) A. Banh et al. CANCER RESEARCH
- The role of galectins in colorectal cancer progression
- (2011) Hannah Barrow et al. INTERNATIONAL JOURNAL OF CANCER
- Regulatory T cells and breast cancer: implications for immunopathogenesis
- (2010) Maria Angelica Ehara Watanabe et al. CANCER AND METASTASIS REVIEWS
- Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
- (2010) Kimberley A. Stannard et al. CANCER LETTERS
- Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
- (2010) V. L. Thijssen et al. CANCER RESEARCH
- TGFß, a Potent Regulator of Tumor Microenvironment and Host Immune Response, Implication for Therapy
- (2010) L. Yang CURRENT MOLECULAR MEDICINE
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune cell infiltration of primary and metastatic lesions: Mechanisms and clinical impact
- (2010) James E. Talmadge SEMINARS IN CANCER BIOLOGY
- Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1
- (2009) Ferenc Kovács-Sólyom et al. IMMUNOLOGY LETTERS
- CD44 Variant Isoforms Promote Metastasis Formation by a Tumor Cell-Matrix Cross-talk That Supports Adhesion and Apoptosis Resistance
- (2009) P. Klingbeil et al. MOLECULAR CANCER RESEARCH
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- The Galectin Profile of the Endothelium
- (2008) Victor L. Thijssen et al. AMERICAN JOURNAL OF PATHOLOGY
- CD44 and EpCAM: Cancer-Initiating Cell Markers
- (2008) Rachid Marhaba et al. CURRENT MOLECULAR MEDICINE
- Role of Stat3 in suppressing anti-tumor immunity
- (2008) Marcin Kortylewski et al. CURRENT OPINION IN IMMUNOLOGY
- Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function
- (2008) Claudia C. Motran et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Galectins: structure, function and therapeutic potential
- (2008) Ri-Yao Yang et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Galectin-Inhibitory Thiodigalactoside Ester Derivatives Have Antimigratory Effects in Cultured Lung and Prostate Cancer Cells
- (2008) Tamara Delaine et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Basis of Metastasis
- (2008) Anne C. Chiang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune escape as a fundamental trait of cancer: focus on IDO
- (2008) G C Prendergast ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started